Advertisement
Home Blog Page 2219

January 2019 Briefing – Diabetes & Endocrinology

0
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for January 2019. This roundup includes...

January 2019 Briefing – Dermatology

0
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for January 2019. This roundup includes the latest...

January 2019 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for January 2019. This roundup includes the latest...

January 2019 Briefing – Allergy

0
Here are what the editors at HealthDay consider to be the most important developments in Allergy for January 2019. This roundup includes the latest...
The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration.

FDA Approves First Generic Version of Advair for Asthma, COPD

0
Medication approved to treat children aged 4 or older with asthma, adults with asthma or COPD
The prevalence of cardiovascular disease is 48.0 percent in adults in the United States based on 2013 to 2016 data

AHA: Nearly Half of U.S. Adults Have Cardiovascular Disease

0
Forty-six percent of U.S. adults have hypertension
Fruit and vegetable intake is very low in the hemodialysis population

Fruit, Vegetable Intake Very Low in Hemodialysis Population

0
Higher consumption of fruit and vegetables linked to lower risk for all-cause, non-CVD mortality
Projected increases in maternal heat exposure may result in increased congenital heart defect burden

Rising Temps May Up Burden of Congenital Heart Disease in U.S.

0
Large increases in specific congenital heart defect subtypes projected in different regions
Women with breast cancer have an increased long-term incidence of atrial fibrillation

Long-Term Incidence of A-Fib Increased in Women With Breast Cancer

0
Women younger than 60 years have increased short-term, longer-term risk
Switching from analogue to human insulin is associated with a small increase in hemoglobin A1c levels

Small Increase in HbA1c Seen With Switch to Human Insulin in T2DM

0
No increase in serious hypoglycemia, hyperglycemia after switch from analogue to human insulin